Midlands, Region in England

International genomics research led by the University of Leicester has used artificial intelligence (AI) to study an aggressive form of cancer, which could improve patient outcomes.Mesothelioma is caused by breathing asbestos particles and most commonly occurs in the linings of the lungs or abdomen. Currently, only seven per cent of people survive five years after diagnosis, with a prognosis averaging 12 to 18 months.New research undertaken by the Leicester Mesothelioma Research Programme has now revealed, using AI analysis of DNA-sequenced mesotheliomas, that they evolve along similar or repeated paths between individuals. These paths predict the aggressiveness and possible therapy of this otherwise incurable cancer.Professor Dean Fennell, Chair of Thoracic Medical Oncology at the University of Leicester and Director of the Leicester Mesothelioma Research Programme, said:"It has long been appreciated that asbestos causes mesothelioma, however, how this occurs remains a mystery."Using AI to interrogate genomic 'big data', this initial work shows us that mesotheliomas follow ordered paths of mutations during development and that these so-called trajectories predict not only how long a patient may survive, but also how to better treat cancer - something Leicester aims to lead on internationally through clinical trial initiatives."While the use of asbestos is now outlawed - and stringent regulations in place on its removal - each year around 25 people are diagnosed with mesothelioma in Leicestershire and 190 are diagnosed in the East Midlands. Cases of mesothelioma in the UK have increased by 61 per cent since the early 1990s.Until very recently, chemotherapy was the only licenced choice for patients with mesothelioma. However, treatment options start to become limited once people stop responding to their treatment.Professor Fennell in collaboration with the University of Southampton recently made a major breakthrough in treating the disease by demonstrating that the use of an immunotherapy drug called nivolumab increased survival and stabilised the disease for patients. This was the first-ever trial to demonstrate improved survival in patients with relapsed mesothelioma.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

MidlandsFOLLOW

Midlands, Latest News

London, Aug 10 Although the UK has witnessed a sharp decline in coronavirus vaccine hesitancy, London still remains ... ...

Eighty percent crowd capacity has been allowed for the third ODI between England and Pakistan at Edgbaston next month ... ...

Birmingham's Edgbaston Stadium has been confirmed as part of the UK Government's Events Research Programme (ERP) and it will operate at 80 per cent capacity for the upcoming One Day International (ODI) between England and Pakistan. ...

The Zimbabwean government has announced a two-week localized lockdown for Hurungwe and Kariba districts in Mashonaland West Province following a spike in COVID-19 infections. ...

TVS Motor Company (TVS), owner of The Norton Motorcycle Co. Ltd. (Norton), is announcing the appointment of Dr. Robert Hentschel as Chief Executive Officer (CEO) and Vittorio Urciuoli as Chief Technical Officer (CTO) of the historic Solihull - based ...

The Mahindra Group has announced the setting up of an advanced design centre at West Midlands in the United Kingdom. ...

A new international genomics research led by the University of Leicester used artificial intelligence (AI) to study an aggressive form of cancer, which could be helpful in improving patient outcomes. ...

International genomics research led by the University of Leicester has used artificial intelligence (AI) to study an aggressive form of cancer, which could improve patient outcomes. ...